These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 36581667)

  • 41. High-Throughput Screening Assays for Cancer Immunotherapy Targets: Ectonucleotidases CD39 and CD73.
    Kumar M; Lowery R; Kumar V
    SLAS Discov; 2020 Mar; 25(3):320-326. PubMed ID: 31868071
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Regulation of CD4
    El-Maadawy EA; Elshal MF; Bakry RM; Moussa MM; El-Naby S; Talaat RM
    Mol Immunol; 2020 Aug; 124():1-8. PubMed ID: 32480291
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Treatment-induced changes of lymphocyte subsets in patients with adenoid cystic carcinoma of the head and neck.
    Jeske SS; Weissinger SE; Veit JA; Brunner C; Huber U; Theodoraki MN; Hoffmann TK; Schuler PJ; Doescher J
    Eur Arch Otorhinolaryngol; 2019 May; 276(5):1465-1473. PubMed ID: 30815724
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Is cellular immunity not impaired after remission induction in acute lymphoblastic leukemia in children].
    Łuczyński W; Stasiak-Barmuta A; Krawczuk-Rybak M; Kasprzycka E; Zak J; Nowakowska M
    Pol Merkur Lekarski; 2004 Jan; 16(91):17-21. PubMed ID: 15080084
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Alteration of the immune environment in bone marrow from children with recurrent B cell precursor acute lymphoblastic leukemia.
    Mikami T; Kato I; Wing JB; Ueno H; Tasaka K; Tanaka K; Kubota H; Saida S; Umeda K; Hiramatsu H; Isobe T; Hiwatari M; Okada A; Chiba K; Shiraishi Y; Tanaka H; Miyano S; Arakawa Y; Oshima K; Koh K; Adachi S; Iwaisako K; Ogawa S; Sakaguchi S; Takita J
    Cancer Sci; 2022 Jan; 113(1):41-52. PubMed ID: 34716967
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Critical stoichiometric ratio of CD4(+)  CD25(+)  FoxP3(+) regulatory T cells and CD4(+)  CD25(-) responder T cells influence immunosuppression in patients with B-cell acute lymphoblastic leukaemia.
    Bhattacharya K; Chandra S; Mandal C
    Immunology; 2014 May; 142(1):124-39. PubMed ID: 24354800
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Structural and functional characterization of engineered bifunctional fusion proteins of CD39 and CD73 ectonucleotidases.
    Zhong EH; Ledderose C; De Andrade Mello P; Enjyoji K; Lunderberg JM; Junger W; Robson SC
    Am J Physiol Cell Physiol; 2021 Jan; 320(1):C15-C29. PubMed ID: 33052071
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Deep lung--cellular reaction to HIV].
    Tavares Marques MA; Alves V; Duque V; Botelho MF
    Rev Port Pneumol; 2007; 13(2):175-212. PubMed ID: 17492233
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Decreased frequency of CD73+CD8+ T cells of HIV-infected patients correlates with immune activation and T cell exhaustion.
    Tóth I; Le AQ; Hartjen P; Thomssen A; Matzat V; Lehmann C; Scheurich C; Beisel C; Busch P; Degen O; Lohse AW; Eiermann T; Fätkenheuer G; Meyer-Olson D; Bockhorn M; Hauber J; van Lunzen J; Schulze Zur Wiesch J
    J Leukoc Biol; 2013 Oct; 94(4):551-61. PubMed ID: 23709688
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inhibition of CD39 enzymatic function at the surface of tumor cells alleviates their immunosuppressive activity.
    Bastid J; Regairaz A; Bonnefoy N; Déjou C; Giustiniani J; Laheurte C; Cochaud S; Laprevotte E; Funck-Brentano E; Hemon P; Gros L; Bec N; Larroque C; Alberici G; Bensussan A; Eliaou JF
    Cancer Immunol Res; 2015 Mar; 3(3):254-65. PubMed ID: 25403716
    [TBL] [Abstract][Full Text] [Related]  

  • 51. CD73 is a phenotypic marker of effector memory Th17 cells in inflammatory bowel disease.
    Doherty GA; Bai A; Hanidziar D; Longhi MS; Lawlor GO; Putheti P; Csizmadia E; Nowak M; Cheifetz AS; Moss AC; Robson SC
    Eur J Immunol; 2012 Nov; 42(11):3062-72. PubMed ID: 22965858
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Lymphocyte subpopulations in Sjögren's syndrome are distinct in anti-SSA-positive patients and related to disease activity.
    Barcelos F; Martins C; Madeira N; Ângelo-Dias M; Cardigos J; Alves N; Vaz-Patto J; Cunha-Branco J; Borrego LM
    Clin Rheumatol; 2021 Jul; 40(7):2791-2804. PubMed ID: 33443605
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Reduction in Proportion of Senescent CD8+ T Lymphocytes During Chemotherapy of Children with Acute Lymphoblastic Leukemia.
    Rutkauskaitė V; Ragelienė L; Matuzevičienė R; Sinkevič K; Mauricas M; Characiejus D
    Anticancer Res; 2016 Nov; 36(11):6195-6199. PubMed ID: 27793951
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Assessment of selected co-stimulatory, adhesion and activatory molecules and cytokines of Th(1)/Th(2) balance in acute lymphoblastic leukemia in children.
    Luczyński W; Stasiak-Barmuta A; Krawczuk-Rybak M; Malinowska I
    Arch Immunol Ther Exp (Warsz); 2005; 53(4):357-63. PubMed ID: 16088321
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Multiplex Single-Cell Analysis of Cancer Cells Enables Unbiased Uncovering Subsets Associated with Cancer Relapse: Heterogeneity of Multidrug Resistance in Precursor B-ALL.
    Zhou Y; Wai-Choi Tse E; Leung R; Cheung E; Li H; Sun H
    ChemMedChem; 2022 Feb; 17(3):e202100638. PubMed ID: 34783169
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evaluation of CD4
    McRae JL; Chia JS; Pommey SA; Dwyer KM
    Nephrology (Carlton); 2017 Jul; 22(7):505-512. PubMed ID: 27517975
    [TBL] [Abstract][Full Text] [Related]  

  • 57. CD19
    Hetta HF; Mwafey IM; Batiha GE; Alomar SY; Mohamed NA; Ibrahim MA; Elkady A; Meshaal AK; Alrefai H; Khodeer DM; Zahran AM
    Vaccines (Basel); 2020 Jun; 8(2):. PubMed ID: 32604936
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Purinergic signaling during intestinal inflammation.
    Longhi MS; Moss A; Jiang ZG; Robson SC
    J Mol Med (Berl); 2017 Sep; 95(9):915-925. PubMed ID: 28547076
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Changes of T Cell Subsets and Their Relationship with Clinical Features and Prognosis in Patients with Acute Leukemia].
    Zheng RH; Yu BD; Zheng LX; Wang CY; Qin PF; Luo XD; Lin JR; Tan H; Xu J
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Oct; 26(5):1309-1316. PubMed ID: 30295243
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Adenosinergic Immunosuppression by Human Mesenchymal Stromal Cells Requires Co-Operation with T cells.
    Kerkelä E; Laitinen A; Räbinä J; Valkonen S; Takatalo M; Larjo A; Veijola J; Lampinen M; Siljander P; Lehenkari P; Alfthan K; Laitinen S
    Stem Cells; 2016 Mar; 34(3):781-90. PubMed ID: 26731338
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.